Skip to main content
logo
Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.23
+0.09 (1.75%)
At close: Aug 5, 2026, 4:00 PM EDT
5.25
+0.02 (0.38%)
After-hours: Aug 5, 2026, 4:10 PM EDT

Valneva SE Revenue

Valneva SE had revenue of 30.90M EUR in the quarter ending March 31, 2026, a decrease of -37.23%. This brings the company's revenue in the last twelve months to 156.33M, down -15.98% year-over-year. In the year 2025, Valneva SE had annual revenue of 174.66M with 3.00% growth.

Revenue (ttm)
156.33M EUR
Revenue Growth
-15.98%
P/S Ratio
2.71
Revenue / Employee
231,942 EUR
Employees
674
Market Cap
488.51M USD

Revenue Chart

Chart
* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025174.66M5.08M3.00%
Dec 31, 2024169.58M15.87M10.32%
Dec 31, 2023153.71M-207.59M-57.46%
Dec 31, 2022361.30M13.22M3.80%
Dec 31, 2021348.09M237.76M215.52%
Dec 31, 2020110.32M-15.88M-12.58%
Dec 31, 2019126.20M13.16M11.64%
Dec 31, 2018113.04M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Autolus Therapeutics92.62M
Assembly Biosciences71.10M
Q32 Bio53.74M
Verastem49.59M
Evommune10.00M
Ovid Therapeutics7.12M
SL Science Holding3.27M
ProKidney889.00K
Revenue Rankings

VALN News

More News